Brincidofovir
CAS 444805-28-1Small Molecule
Overview
Brincidofovir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL203321).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Brincidofovir expires 10 Oct 2034 and exclusivity 4 Jun 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid
- Canonical SMILES
- CCCCCCCCCCCCCCCCOCCCOP(=O)(CO[C@@H](CN1C=CC(=NC1=O)N)CO)O
- InChIKey
- WXJFKKQWPMNTIM-VWLOTQADSA-N
Verified Supplier Partner
Do you supply Brincidofovir? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.